Date Title Description PDF
10 May 2023 On P&L The Company releases the first quarter 2023 financial results presentation Download
10 May 2023 On P&L The Company releases the press release related to the first quarter 2023 financial results Download
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The Company releases the full year 2022 financial results presentation. Download
21 Feb 2023 On business and financial situation The Company releases the press release related to the full year 2022 financial results. Download

Pages

Date Title Description PDF
08 May 2025 On business and financial situation ROVI informs on the award of a grant in its favor to develop the R&D Project IPCEI - ROVI (LAISOLID) Download
04 Apr 2025 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the first quarter of 2025 Download
25 Feb 2025 Annual Financial Reports and Audit Reports The Company submits the 2024 Annual Financial Report  Download
25 Feb 2025 Annual Report regarding remuneration of the members of the Board of Directors ROVI releases the 2024 annual report regarding remuneration of the members of the Board of Directors Download
07 Jan 2025 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the fourth quarter of 2024 Download

Pages

Date Title Description PDF
28 Jul 2016 Información sobre resultados (2) ROVI releases the press release related to the 2016 first half results Download
28 Jul 2016 Información sobre resultados ROVI releases the presentation related to the 2016 first half results Download
05 Jul 2016 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the second quarter of 2016 Download
24 Jun 2016 Información sobre dividendos The Company informs about the dividends payment Download
31 May 2016 Convocatorias y acuerdos de Juntas y Asambleas generales ROVI releases the information related to the agreements adopted by the 2016 General Shareholders Meeting Download

Pages